KNDI [Kandi Technologies] 8-K: (Original Filing)
[]
SPU [SkyPeople Fruit Juice] 8-K: (Original Filing)
[COMPANY SkyPeople Fruit Juice, Inc. Mr. Xin Ma, CFO Tel: China + 86 - 29-8837-7161 Email: oliver.x.ma@skypeoplefruitjuice.com Web: http://www.skypeoplefruitjuice.com INVESTOR RELATIONS David Rudnick , Account Manager CCG Investor Relations Tel: US +1- 646 - 626-4172 Email: david.rudnick@ccgir.com Web: http://www.ccgir.com SkyPeople Fruit Juice, Inc. Appoints Mr. Xin Ma as Chief Financial Officer SPU News . XI'AN, China , May 2, 2012] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): May 2, 2012 SKYPEOPLE FRUIT JUICE, INC. Florida 001-34502 98-0222013 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 16F, China Development Bank Tower, No. 2, Gaoxin 1st Road, Xi’an, PRC 710075 (Zip code) 86-29-88377161]
SPU [SkyPeople Fruit Juice] 8-K: COMPANY SkyPeople Fruit Juice, Inc. Mr. Xin Ma,
[COMPANY SkyPeople Fruit Juice, Inc. Mr. Xin Ma, CFO Tel: China + 86 - 29-8837-7161 Email: oliver.x.ma@skypeoplefruitjuice.com Web: http://www.skypeoplefruitjuice.com INVESTOR RELATIONS David Rudnick , Account Manager CCG Investor Relations Tel: US +1- 646 - 626-4172 Email: david.rudnick@ccgir.com Web: http://www.ccgir.com SkyPeople Fruit Juice, Inc. Appoints Mr. Xin Ma as Chief Financial Officer SPU News . XI'AN, China , May 2, 2012] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): May 2, 2012 SKYPEOPLE FRUIT JUICE, INC. Florida 001-34502 98-0222013 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 16F, China Development Bank Tower, No. 2, Gaoxin 1st Road, Xi’an, PRC 710075 (Zip code) 86-29-88377161]
CPHI [CHINA PHARMAS,] 8-K: (Original Filing)
[AMENDMENT AGREEMENT TO NON-QUALIFIED STOCK OPTION AGREEMENTS OF CHINA PHARMA HOLDINGS, INC WHEREAS, the Employment Agreement by and between the Company and the Optionee will cease its effect as of April 28, 2012; WHEREAS, the Nominating and Compensation Committee believes it is for the best interest of the Company to terminate the Subject Options on April 28, 2012 and the]
CPHI [CHINA PHARMAS,] 8-K: AMENDMENT AGREEMENT TO NON-QUALIFIED STOCK OPTION AGREEMENTS OF
[AMENDMENT AGREEMENT TO NON-QUALIFIED STOCK OPTION AGREEMENTS OF CHINA PHARMA HOLDINGS, INC WHEREAS, the Employment Agreement by and between the Company and the Optionee will cease its effect as of April 28, 2012; WHEREAS, the Nominating and Compensation Committee believes it is for the best interest of the Company to terminate the Subject Options on April 28, 2012 and the]
CPHI [CHINA PHARMAS,] 8-K: AMENDMENTREEMENT TO NON-QUALIFIED STOCK OPTIONREEMENTS OF CHINA PHARMAS,
[AMENDMENTREEMENT TO NON-QUALIFIED STOCK OPTIONREEMENTS OF CHINA PHARMAS, WHEREAS, the Employmentreement by and between thempany and the Optionee will cease its effect of April 28, 2012; WHEREAS, the Nominating andmpensationmmittee believes it is for the best interest of thempany to terminate the Subject Options on April 28, 2012 and the Optioneereed to.]
SOHU [SOHU COM] 8-K: (Original Filing)
[SOHU.COM REPORTS FIRST QUARTER 2012 UNAUDITED FINANCIAL RESULTS Total Revenues were US$227 Million, Up 30% Year-over-Year GAAP Net Income Before Non-Controlling Interest was US$41 Million, Non-GAAP Net Income Before Non-Controlling Interest was US$45 Million, Exceeding the High End of Group Guidance by US$4 Million; GAAP Fully Diluted EPS of US$0.53, Non-GAAP Fully Diluted EPS of US$0.61, Exceeding the High End] []
SOHU [SOHU COM] 8-K: SOHU.COM REPORTS FIRST QUARTER 2012 UNAUDITED FINANCIAL RESULTS
[SOHU.COM REPORTS FIRST QUARTER 2012 UNAUDITED FINANCIAL RESULTS Total Revenues were US$227 Million, Up 30% Year-over-Year GAAP Net Income Before Non-Controlling Interest was US$41 Million, Non-GAAP Net Income Before Non-Controlling Interest was US$45 Million, Exceeding the High End of Group Guidance by US$4 Million; GAAP Fully Diluted EPS of US$0.53, Non-GAAP Fully Diluted EPS of US$0.61, Exceeding the High End] []
KNDI [Kandi Technologies] 8-K: (Original Filing)
[Kandi Technologies Chairman Donates Personal Ownership of 11 Pure EV Patents to the Company China JINHUA, 2012 Kandi Technologies, Corp. (the 'Company' or 'Kandi') (NASDAQ: KNDI), electric vehicles The eleven donated patents include: · One patent relating to the chassis of electric vehicles equipped with a removable battery module · Three patents for EV battery exchange systems · One patent] []
